Specialty Retail
Compare Stocks
5 / 10Stock Comparison
NVVE vs AMPY vs EVGO vs TPVG vs CHPT
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Exploration & Production
Specialty Retail
Asset Management
Specialty Retail
NVVE vs AMPY vs EVGO vs TPVG vs CHPT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Specialty Retail | Oil & Gas Exploration & Production | Specialty Retail | Asset Management | Specialty Retail |
| Market Cap | $318K | $221M | $596M | $243M | $134M |
| Revenue (TTM) | $5M | $263M | $418M | $97M | $411M |
| Net Income (TTM) | $-30M | $44M | $-47M | $-12M | $-220M |
| Gross Margin | 36.3% | 93.2% | 20.2% | 83.5% | 30.5% |
| Operating Margin | -6.7% | 29.2% | -26.3% | 77.9% | -51.1% |
| Forward P/E | — | 20.1x | — | 6.5x | — |
| Total Debt | $11M | $3M | $107M | $469M | $272M |
| Cash & Equiv. | $371K | $61M | $151M | $20M | $142M |
NVVE vs AMPY vs EVGO vs TPVG vs CHPT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Nov 20 | May 26 | Return |
|---|---|---|---|
| Nuvve Holding Corp. (NVVE) | 100 | 0.0 | -100.0% |
| Amplify Energy Corp. (AMPY) | 100 | 537.6 | +437.6% |
| EVgo, Inc. (EVGO) | 100 | 19.1 | -80.9% |
| TriplePoint Venture… (TPVG) | 100 | 46.5 | -53.5% |
| ChargePoint Holding… (CHPT) | 100 | 0.9 | -99.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: NVVE vs AMPY vs EVGO vs TPVG vs CHPT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
NVVE is the clearest fit if your priority is income & stability.
- Dividend streak 1 yrs, beta 1.97
AMPY is the #2 pick in this set and the best alternative if long-term compounding is your priority.
- 9.0% 10Y total return vs TPVG's 93.3%
- +101.9% vs NVVE's -66.5%
- 6.2% ROA vs NVVE's -178.0%, ROIC 12.3% vs -153.8%
EVGO ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 49.6%, EPS growth 24.4%, 3Y rev CAGR 91.6%
- Lower volatility, beta 2.04, Low D/E 27.7%, current ratio 2.19x
- Beta 2.04, current ratio 2.19x
- 49.6% revenue growth vs NVVE's -36.6%
TPVG carries the broadest edge in this set and is the clearest fit for value and quality.
- Better valuation composite
- 50.6% margin vs NVVE's -6.4%
- Beta 0.83 vs CHPT's 2.61, lower leverage
- 17.1% yield; the other 4 pay no meaningful dividend
Among these 5 stocks, CHPT doesn't own a clear edge in any measured category.
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 49.6% revenue growth vs NVVE's -36.6% | |
| Value | Better valuation composite | |
| Quality / Margins | 50.6% margin vs NVVE's -6.4% | |
| Stability / Safety | Beta 0.83 vs CHPT's 2.61, lower leverage | |
| Dividends | 17.1% yield; the other 4 pay no meaningful dividend | |
| Momentum (1Y) | +101.9% vs NVVE's -66.5% | |
| Efficiency (ROA) | 6.2% ROA vs NVVE's -178.0%, ROIC 12.3% vs -153.8% |
NVVE vs AMPY vs EVGO vs TPVG vs CHPT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
NVVE vs AMPY vs EVGO vs TPVG vs CHPT — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMPY leads in 4 of 6 categories
NVVE leads 0 • EVGO leads 0 • TPVG leads 0 • CHPT leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — AMPY and TPVG each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
EVGO is the larger business by revenue, generating $418M annually — 89.9x NVVE's $5M. TPVG is the more profitable business, keeping 50.6% of every revenue dollar as net income compared to NVVE's -6.4%. On growth, EVGO holds the edge at +45.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $5M | $263M | $418M | $97M | $411M |
| EBITDAEarnings before interest/tax | -$31M | $109M | -$39M | -$22M | -$180M |
| Net IncomeAfter-tax profit | -$30M | $44M | -$47M | -$12M | -$220M |
| Free Cash FlowCash after capex | -$16M | -$13.5B | -$165M | $35M | -$67M |
| Gross MarginGross profit ÷ Revenue | +36.3% | +93.2% | +20.2% | +83.5% | +30.5% |
| Operating MarginEBIT ÷ Revenue | -6.7% | +29.2% | -26.3% | +77.9% | -51.1% |
| Net MarginNet income ÷ Revenue | -6.4% | +16.7% | -11.1% | +50.6% | -53.5% |
| FCF MarginFCF ÷ Revenue | -3.4% | -51.1% | -39.5% | -58.7% | -16.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -16.7% | -18.1% | +45.5% | — | +7.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +90.3% | +8394.1% | -66.7% | -2.3% | +28.8% |
Valuation Metrics
AMPY leads this category, winning 2 of 5 comparable metrics.
Valuation Metrics
At 4.9x trailing earnings, TPVG trades at a 7% valuation discount to AMPY's 5.3x P/E. On an enterprise value basis, AMPY's 1.5x EV/EBITDA is more attractive than TPVG's 9.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $317,951 | $221M | $596M | $243M | $134M |
| Enterprise ValueMkt cap + debt − cash | $11M | $163M | $552M | $691M | $263M |
| Trailing P/EPrice ÷ TTM EPS | -0.01x | 5.27x | -6.13x | 4.91x | -0.65x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.11x | — | 6.50x | — |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 4.84x | — |
| EV / EBITDAEnterprise value multiple | — | 1.49x | — | 9.13x | — |
| Price / SalesMarket cap ÷ Revenue | 0.06x | 0.84x | 1.55x | 2.50x | 0.32x |
| Price / BookPrice ÷ Book value/share | — | 0.48x | 0.66x | 0.68x | 6.77x |
| Price / FCFMarket cap ÷ FCF | — | — | — | — | — |
Profitability & Efficiency
AMPY leads this category, winning 8 of 9 comparable metrics.
Profitability & Efficiency
AMPY delivers a 10.6% return on equity — every $100 of shareholder capital generates $11 in annual profit, vs $-6 for NVVE. AMPY carries lower financial leverage with a 0.01x debt-to-equity ratio, signaling a more conservative balance sheet compared to CHPT's 12.75x. On the Piotroski fundamental quality scale (0–9), AMPY scores 7/9 vs NVVE's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -6.1% | +10.6% | -12.2% | -3.4% | -3.5% |
| ROA (TTM)Return on assets | -178.0% | +6.2% | -5.1% | -1.5% | -25.8% |
| ROICReturn on invested capital | -153.8% | +12.3% | -21.9% | +7.2% | -83.8% |
| ROCEReturn on capital employed | -2.2% | +12.6% | -14.5% | +9.4% | -41.6% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 7 | 6 | 5 | 5 |
| Debt / EquityFinancial leverage | — | 0.01x | 0.28x | 1.33x | 12.75x |
| Net DebtTotal debt minus cash | $10M | -$58M | -$44M | $449M | $130M |
| Cash & Equiv.Liquid assets | $371,497 | $61M | $151M | $20M | $142M |
| Total DebtShort + long-term debt | $11M | $3M | $107M | $469M | $272M |
| Interest CoverageEBIT ÷ Interest expense | -13.39x | — | -11.79x | -1.02x | -8.58x |
Total Returns (Dividends Reinvested)
AMPY leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in AMPY five years ago would be worth $18,100 today (with dividends reinvested), compared to $1 for NVVE. Over the past 12 months, AMPY leads with a +101.9% total return vs NVVE's -66.5%. The 3-year compound annual growth rate (CAGR) favors TPVG at -1.2% vs NVVE's -88.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -85.5% | +17.3% | -38.3% | -6.3% | -12.5% |
| 1-Year ReturnPast 12 months | -66.5% | +101.9% | -48.2% | +19.3% | -48.3% |
| 3-Year ReturnCumulative with dividends | -99.8% | -21.9% | -70.5% | -3.4% | -96.6% |
| 5-Year ReturnCumulative with dividends | -100.0% | +81.0% | -83.7% | -13.5% | -98.6% |
| 10-Year ReturnCumulative with dividends | -100.0% | +904.1% | -80.6% | +93.3% | -96.8% |
| CAGR (3Y)Annualised 3-year return | -88.3% | -7.9% | -33.4% | -1.2% | -67.6% |
Risk & Volatility
AMPY leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
AMPY is the less volatile stock with a -0.19 beta — it tends to amplify market swings less than CHPT's 2.61 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. AMPY currently trades 80.0% from its 52-week high vs NVVE's 4.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.97x | -0.19x | 2.04x | 0.83x | 2.61x |
| 52-Week HighHighest price in past year | $7.96 | $6.79 | $5.18 | $7.53 | $17.78 |
| 52-Week LowLowest price in past year | $0.15 | $2.60 | $1.64 | $4.48 | $4.45 |
| % of 52W HighCurrent price vs 52-week peak | +4.4% | +80.0% | +36.7% | +79.5% | +34.6% |
| RSI (14)Momentum oscillator 0–100 | 33.7 | 41.4 | 40.1 | 58.3 | 55.0 |
| Avg Volume (50D)Average daily shares traded | 868K | 1.0M | 4.4M | 504K | 474K |
Analyst Outlook
Evenly matched — NVVE and CHPT each lead in 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: AMPY as "Buy", EVGO as "Buy", TPVG as "Hold", CHPT as "Hold". Consensus price targets imply 176.3% upside for EVGO (target: $5) vs 21.8% for CHPT (target: $8). TPVG is the only dividend payer here at 17.11% yield — a key consideration for income-focused portfolios.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $10.25 | $5.25 | $8.95 | $7.50 |
| # AnalystsCovering analysts | — | 5 | 16 | 12 | 21 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +17.1% | — |
| Dividend StreakConsecutive years of raises | 1 | 0 | — | 0 | 1 |
| Dividend / ShareAnnual DPS | — | — | — | $1.02 | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
AMPY leads in 4 of 6 categories — strongest in Valuation Metrics and Profitability & Efficiency. 2 categories are tied.
NVVE vs AMPY vs EVGO vs TPVG vs CHPT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is NVVE or AMPY or EVGO or TPVG or CHPT a better buy right now?
For growth investors, EVgo, Inc.
(EVGO) is the stronger pick with 49. 6% revenue growth year-over-year, versus -36. 6% for Nuvve Holding Corp. (NVVE). TriplePoint Venture Growth BDC Corp. (TPVG) offers the better valuation at 4. 9x trailing P/E (6. 5x forward), making it the more compelling value choice. Analysts rate Amplify Energy Corp. (AMPY) a "Buy" — based on 5 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — NVVE or AMPY or EVGO or TPVG or CHPT?
On trailing P/E, TriplePoint Venture Growth BDC Corp.
(TPVG) is the cheapest at 4. 9x versus Amplify Energy Corp. at 5. 3x. On forward P/E, TriplePoint Venture Growth BDC Corp. is actually cheaper at 6. 5x.
03Which is the better long-term investment — NVVE or AMPY or EVGO or TPVG or CHPT?
Over the past 5 years, Amplify Energy Corp.
(AMPY) delivered a total return of +81. 0%, compared to -100. 0% for Nuvve Holding Corp. (NVVE). Over 10 years, the gap is even starker: AMPY returned +904. 1% versus NVVE's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — NVVE or AMPY or EVGO or TPVG or CHPT?
By beta (market sensitivity over 5 years), Amplify Energy Corp.
(AMPY) is the lower-risk stock at -0. 19β versus ChargePoint Holdings, Inc. 's 2. 61β — meaning CHPT is approximately -1487% more volatile than AMPY relative to the S&P 500. On balance sheet safety, Amplify Energy Corp. (AMPY) carries a lower debt/equity ratio of 1% versus 13% for ChargePoint Holdings, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — NVVE or AMPY or EVGO or TPVG or CHPT?
By revenue growth (latest reported year), EVgo, Inc.
(EVGO) is pulling ahead at 49. 6% versus -36. 6% for Nuvve Holding Corp. (NVVE). On earnings-per-share growth, the picture is similar: Amplify Energy Corp. grew EPS 232. 3% year-over-year, compared to 24. 4% for EVgo, Inc.. Over a 3-year CAGR, EVGO leads at 91. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — NVVE or AMPY or EVGO or TPVG or CHPT?
TriplePoint Venture Growth BDC Corp.
(TPVG) is the more profitable company, earning 50. 6% net margin versus -329. 1% for Nuvve Holding Corp. — meaning it keeps 50. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TPVG leads at 77. 9% versus -387. 1% for NVVE. At the gross margin level — before operating expenses — AMPY leads at 93. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is NVVE or AMPY or EVGO or TPVG or CHPT more undervalued right now?
On forward earnings alone, TriplePoint Venture Growth BDC Corp.
(TPVG) trades at 6. 5x forward P/E versus 20. 1x for Amplify Energy Corp. — 13. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EVGO: 176. 3% to $5. 25.
08Which pays a better dividend — NVVE or AMPY or EVGO or TPVG or CHPT?
In this comparison, TPVG (17.
1% yield) pays a dividend. NVVE, AMPY, EVGO, CHPT do not pay a meaningful dividend and should not be held primarily for income.
09Is NVVE or AMPY or EVGO or TPVG or CHPT better for a retirement portfolio?
For long-horizon retirement investors, Amplify Energy Corp.
(AMPY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 19), +904. 1% 10Y return). ChargePoint Holdings, Inc. (CHPT) carries a higher beta of 2. 61 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMPY: +904. 1%, CHPT: -96. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between NVVE and AMPY and EVGO and TPVG and CHPT?
These companies operate in different sectors (NVVE (Consumer Cyclical) and AMPY (Energy) and EVGO (Consumer Cyclical) and TPVG (Financial Services) and CHPT (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: NVVE is a small-cap quality compounder stock; AMPY is a small-cap deep-value stock; EVGO is a small-cap high-growth stock; TPVG is a small-cap high-growth stock; CHPT is a small-cap quality compounder stock. TPVG pays a dividend while NVVE, AMPY, EVGO, CHPT do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.